These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33031221)

  • 1. FOXP3 mRNA Profile Prognostic of Acute T Cell-mediated Rejection and Human Kidney Allograft Survival.
    Luan D; Dadhania DM; Ding R; Muthukumar T; Lubetzky M; Lee JR; Sharma VK; August P; Mueller FB; Schwartz JE; Suthanthiran M
    Transplantation; 2021 Aug; 105(8):1825-1839. PubMed ID: 33031221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Messenger RNA for FOXP3 in the urine of renal-allograft recipients.
    Muthukumar T; Dadhania D; Ding R; Snopkowski C; Naqvi R; Lee JB; Hartono C; Li B; Sharma VK; Seshan SV; Kapur S; Hancock WW; Schwartz JE; Suthanthiran M
    N Engl J Med; 2005 Dec; 353(22):2342-51. PubMed ID: 16319383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary cell mRNA profiling of kidney allograft recipients: Development of a portable protocol for noninvasive diagnosis of T cell mediated rejection and BK virus nephropathy.
    Salinas T; Li C; Snopkowski C; Stryjniak G; Shankaranarayanan D; Albakry S; Ding R; Sharma VK; Salvatore SP; Seshan SV; Dadhania DM; Muthukumar T; Suthanthiran M
    J Immunol Methods; 2023 Jan; 512():113402. PubMed ID: 36493873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection.
    Alachkar H; Mutonga M; Kato T; Kalluri S; Kakuta Y; Uemura M; Imamura R; Nonomura N; Vujjini V; Alasfar S; Rabb H; Nakamura Y; Alachkar N
    BMC Nephrol; 2016 Nov; 17(1):181. PubMed ID: 27871261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
    Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
    Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
    Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection.
    Bouatou Y; Viglietti D; Pievani D; Louis K; Duong Van Huyen JP; Rabant M; Aubert O; Taupin JL; Glotz D; Legendre C; Loupy A; Lefaucheur C
    Am J Transplant; 2019 Jul; 19(7):1972-1988. PubMed ID: 30748089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of Urinary PD-1 and FOXP3 mRNA in a Cohort of Egyptian Renal Allograft Recipients.
    Abd Elaziz MM; Bakry S; M Abd ElAal AE; Rashed L; Hesham D
    Ann Transplant; 2016 Jan; 21():17-24. PubMed ID: 26753722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of revised criteria for chronic active T cell-mediated rejection in the 2017 Banff classification: Surveillance by 1-year protocol biopsies for kidney transplantation.
    Nakagawa K; Tsuchimoto A; Ueki K; Matsukuma Y; Okabe Y; Masutani K; Unagami K; Kakuta Y; Okumi M; Nakamura M; Nakano T; Tanabe K; Kitazono T;
    Am J Transplant; 2021 Jan; 21(1):174-185. PubMed ID: 32484280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forkhead box protein 3 mRNA expression in the peripheral blood of kidney-transplant recipients with acute rejection.
    Wang W; Li XB; Yang XY; Zhang XD
    Chin Med J (Engl); 2011 Jun; 124(12):1775-8. PubMed ID: 21740831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samples.
    Christakoudi S; Runglall M; Mobillo P; Tsui TL; Duff C; Domingo-Vila C; Kamra Y; Delaney F; Montero R; Spiridou A; Kassimatis T; Phin-Kon S; Tucker B; Farmer C; Strom TB; Lord GM; Rebollo-Mesa I; Stahl D; Sacks S; Hernandez-Fuentes MP; Chowdhury P
    EBioMedicine; 2019 Mar; 41():571-583. PubMed ID: 30833191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term kidney allograft survival in patients with transplant glomerulitis.
    Nabokow A; Dobronravov VA; Khrabrova M; Gröne HJ; Gröne E; Hallensleben M; Kieneke D; Weithofer P; Smirnov AV; Kliem V
    Transplantation; 2015 Feb; 99(2):331-9. PubMed ID: 25594551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th-17 Alloimmune Responses in Renal Allograft Biopsies From Recipients of Kidney Transplants Using Extended Criteria Donors During Acute T Cell-Mediated Rejection.
    Matignon M; Aissat A; Canoui-Poitrine F; Grondin C; Pilon C; Desvaux D; Saadoun D; Barathon Q; Garrido M; Audard V; Rémy P; Lang P; Cohen J; Grimbert P
    Am J Transplant; 2015 Oct; 15(10):2718-25. PubMed ID: 25989263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
    Cherukuri A; Mehta R; Sharma A; Sood P; Zeevi A; Tevar AD; Rothstein DM; Hariharan S
    Kidney Int; 2019 Jul; 96(1):202-213. PubMed ID: 31029504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts.
    Mueller FB; Yang H; Lubetzky M; Verma A; Lee JR; Dadhania DM; Xiang JZ; Salvatore SP; Seshan SV; Sharma VK; Elemento O; Suthanthiran M; Muthukumar T
    JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Cell mRNA Profiles Predictive of Human Kidney Allograft Status.
    Lubetzky ML; Salinas T; Schwartz JE; Suthanthiran M
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1565-1577. PubMed ID: 33906907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary cell mRNA profiling of kidney allograft recipients: A systematic investigation of a filtration based protocol for the simplification of urine processing.
    Snopkowski C; Salinas T; Li C; Stryjniak G; Ding R; Sharma V; Suthanthiran M
    J Immunol Methods; 2021 Nov; 498():113132. PubMed ID: 34464607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and pathological significance of borderline T cell-mediated rejection.
    Nankivell BJ; Agrawal N; Sharma A; Taverniti A; P'Ng CH; Shingde M; Wong G; Chapman JR
    Am J Transplant; 2019 May; 19(5):1452-1463. PubMed ID: 30501008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of FOXP3 gene and protein expressions in renal allograft biopsies and their association with graft outcomes.
    Dummer CD; Carpio VN; da Silva Loreto M; Joelsons G; Carraro DM; Olivieri ER; Manfro RC; Gonçalves LF; Veronese FV
    Ren Fail; 2013; 35(4):521-30. PubMed ID: 23438049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft Rejection.
    Schiffer L; Wiehler F; Bräsen JH; Gwinner W; Greite R; Kreimann K; Thorenz A; Derlin K; Teng B; Rong S; von Vietinghoff S; Haller H; Mengel M; Pape L; Lerch C; Schiffer M; Gueler F
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.